Cancer Prevention Pharmaceuticals Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$70.3M
Cancer Prevention Pharmaceuticals General Information
Description
Developer of treatment therapies designed to reduce the risk and recurrence of cancer and rare diseases. The company develops therapeutic agents, diagnostics, and lifestyle recommendations for the treatment of risk factors for cancer and also develops cancer chemoprevention indications for common cancers along with prevention and therapeutic strategies in certain rare cancers, enabling patients and physicians to prevent cancer or the recurrence of cancer by identifying and treating the cancer risk factors early.
Contact Information
Website
www.canprevent.comCorporate Office
- 1760 East River Road
- Suite 250
- Tucson, AZ 85718
- United States
Corporate Office
- 1760 East River Road
- Suite 250
- Tucson, AZ 85718
- United States
Cancer Prevention Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 15-Jun-2022 | $70.3M | Completed | Clinical Trials - General | ||
| 7. Later Stage VC | 29-Jan-2021 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC | 14-Sep-2017 | Completed | Clinical Trials - General | |||
| 5. IPO | 02-Nov-2016 | Cancelled | Clinical Trials - General | |||
| 4. Later Stage VC (Series A2) | 31-Oct-2013 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A1) | 01-Sep-2012 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2012 | $230K | $230K | Completed | Startup | |
| 1. Grant | 02-Dec-2010 | $240K | Completed | Startup |
Cancer Prevention Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 |
Cancer Prevention Pharmaceuticals Comparisons
Industry
Financing
Details
Cancer Prevention Pharmaceuticals Competitors (10)
One of Cancer Prevention Pharmaceuticals’s 10 competitors is Immetas, a Venture Capital-Backed company based in East Hanover, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immetas | Venture Capital-Backed | East Hanover, NJ | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Emtora Biosciences | Venture Capital-Backed | San Antonio, TX | ||||
| StemSynergy Therapeutics | Venture Capital-Backed | Miami, FL | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA |
Cancer Prevention Pharmaceuticals Patents
Cancer Prevention Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3235787-A1 | Methods of treating patients having type 1 diabetes with eflornithine | Pending | 02-Nov-2021 | ||
| US-20260137642-A1 | Methods of treating patients having type 1 diabetes with eflornithine | Pending | 02-Nov-2021 | ||
| WO-2023081612-A1 | Methods of treating patients having type 1 diabetes with eflornithine | Inactive | 02-Nov-2021 | ||
| CA-3139162-A1 | Methods for treating familial adenomatous polyposis | Active | 17-May-2019 | ||
| US-20220040130-A1 | Methods for treating familial adenomatous polyposis | Inactive | 17-May-2019 | A61K31/198 |
Cancer Prevention Pharmaceuticals Signals
Cancer Prevention Pharmaceuticals Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arizona Commerce Authority | Government | Minority | ||
| Arizona Tech Investors | Angel Group | Minority | ||
| DVI Equity Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Desert Angels | Angel Group | Minority |
Cancer Prevention Pharmaceuticals FAQs
-
When was Cancer Prevention Pharmaceuticals founded?
Cancer Prevention Pharmaceuticals was founded in 2008.
-
Where is Cancer Prevention Pharmaceuticals headquartered?
Cancer Prevention Pharmaceuticals is headquartered in Tucson, AZ.
-
What is the size of Cancer Prevention Pharmaceuticals?
Cancer Prevention Pharmaceuticals has 14 total employees.
-
What industry is Cancer Prevention Pharmaceuticals in?
Cancer Prevention Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Cancer Prevention Pharmaceuticals a private or public company?
Cancer Prevention Pharmaceuticals is a Private company.
-
What is the current valuation of Cancer Prevention Pharmaceuticals?
The current valuation of Cancer Prevention Pharmaceuticals is .
-
What is Cancer Prevention Pharmaceuticals’s current revenue?
The current revenue for Cancer Prevention Pharmaceuticals is .
-
How much funding has Cancer Prevention Pharmaceuticals raised over time?
Cancer Prevention Pharmaceuticals has raised $18.8M.
-
Who are Cancer Prevention Pharmaceuticals’s investors?
Arizona Commerce Authority, Arizona Tech Investors, DVI Equity Partners, , and Desert Angels are 5 of 11 investors who have invested in Cancer Prevention Pharmaceuticals.
-
Who are Cancer Prevention Pharmaceuticals’s competitors?
Immetas, Centrose, Emtora Biosciences, StemSynergy Therapeutics, and Aura Biosciences are some of the 10 competitors of Cancer Prevention Pharmaceuticals.
-
When was Cancer Prevention Pharmaceuticals acquired?
Cancer Prevention Pharmaceuticals was acquired on 15-Jun-2022.
-
Who acquired Cancer Prevention Pharmaceuticals?
Cancer Prevention Pharmaceuticals was acquired by Panbela Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process